---
title: "Jupiter Endovascular announce US FDA approval for SPIRARE II trial"
date: "2024-08-30T08:39:25.000Z"
publishedDate: "30 août 2024"
summary: "Jupiter Endovascular has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) application for the SPIRARE II US pivotal study. The pivotal trial will study the Vertex pulmonary embolectomy system, which incorporates Jupiter’s Endoportal Control platform technology into endovascular procedures intended to treat acute pulmonary embolism (PE)."
importance: ""
sourceUrl: "https://interventionalnews.com/jupiter-endovascular-announce-us-fda-approval-for-spirare-ii-pivotal-trial/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2024-08-30-jupiter-endovascular-announce-us-fda-approval-for-spirare-ii-trial"
imageUrl: "http://interventionalnews.com/wp-content/uploads/sites/13/2024/08/Jupiter-product-image-8.16.24.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/jupiter-endovascular-announce-us-fda-approval-for-spirare-ii-pivotal-trial/"
---

![Jupiter Endovascular announce US FDA approval for SPIRARE II trial](http://interventionalnews.com/wp-content/uploads/sites/13/2024/08/Jupiter-product-image-8.16.24.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/jupiter-endovascular-announce-us-fda-approval-for-spirare-ii-pivotal-trial/*

## L’essentiel

Jupiter Endovascular has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) application for the SPIRARE II US pivotal study. The pivotal trial will study the Vertex pulmonary embolectomy system, which incorporates Jupiter’s Endoportal Control platform technology into endovascular procedures intended to treat acute pulmonary embolism (PE).

## Lien source

https://interventionalnews.com/jupiter-endovascular-announce-us-fda-approval-for-spirare-ii-pivotal-trial/
